PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,015,000 | +80.9% | 735,307 | +123.8% | 0.10% | +121.7% |
| Q3 2017 | $1,114,000 | +39.4% | 328,619 | +1.5% | 0.05% | +53.3% |
| Q2 2017 | $799,000 | +8.7% | 323,608 | 0.0% | 0.03% | +11.1% |
| Q1 2017 | $735,000 | +7.1% | 323,608 | +0.0% | 0.03% | 0.0% |
| Q4 2016 | $686,000 | -84.3% | 323,467 | -28.1% | 0.03% | -84.9% |
| Q2 2014 | $4,356,000 | +11.6% | 450,047 | -4.1% | 0.18% | +9.1% |
| Q1 2014 | $3,902,000 | -5.8% | 469,514 | -4.3% | 0.16% | +1.2% |
| Q4 2013 | $4,141,000 | +14.6% | 490,600 | +8.3% | 0.16% | +2.5% |
| Q3 2013 | $3,612,000 | +3.3% | 453,163 | +0.1% | 0.16% | -10.2% |
| Q2 2013 | $3,496,000 | – | 452,878 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |